Warning Issued by FDA on consumption of the drug Tysabri used to treat Multiple Sclerosis
Recently the Food and Drug Administration (FDA) issued a public health advisory to inform patients and health care // providers about the suspended marketing of Tysabri (nataluzimab) the drug meant to treat relapsing forms of multiple sclerosis (MS) which was approved by the FDA in 2004. .. ..FDA supports the decision to voluntarily suspend marketing of the drug as well as the use of the product...FDA Issues Public Health Advisory on Tysabri, a New Drug for MS
The Food and Drug Administration (FDA) today issued a public health advisory to inform patients and health care // providers about the suspended marketing of Tysabri (nataluzimab) while the agency and the manufacturer evaluate two serious adverse events reported with its use... ....Tysabri, which received accelerated approval from FDA in November 2004, is an innovative treatment that represents a...Multiple Sclerosis drug, Tysabri banned due to neurological disorders
Tysabri, which is used in the treatment of Multiple Sclerosis (MS), has been withdrawn from market after the two patients taking the drug complained of neurological disorders. The relationship between the drug and // Progressive Multifocal Leukoencephalopathy (PML) is being researched by the scientists. If the drug is deemed to pose a significant risk, it could be a serious setback for the entire...